OCEA — Deadline for Compliance with Nasdaq Listing Rules for Ocean Biomedical, Inc.
Jun 2, 2025, 5:00:00 AM UTC
Summary
Ocean Biomedical, Inc. faces a compliance deadline with Nasdaq on June 2, 2025, after receiving notification on December 3, 2024, regarding its failure to meet the minimum bid price requirement of $1 per share for listed securities. The company has a 180-day compliance period to rectify this situation. If it fails to regain compliance, Ocean Biomedical may become eligible for an extension or face potential delisting from Nasdaq. Regaining compliance is critical to maintaining investor confidence and avoiding disruption to capital-raising efforts.
Company
OCEAN BIOMEDICAL INC (OCEA)NASDAQ — Healthcare, Biotechnology
www.oceanbiomedical.comSimilar Events
Deadline for Compliance with Nasdaq Listing Rules
Nuvve Holding Corp. has received a notice from Nasdaq regarding non-compliance with Listing Rule 5605, which requires a majority of independent directors on the Board and at least three independent directors on the Audit Committee. Following the resignation of Angela Strand, Nuvve has until September 29, 2025, to rectify the issue, potentially by appointing an additional independent director. The company's stock will continue to trade on Nasdaq without immediate effect from this notice.
Cure Period Deadline for Nasdaq ComplianceDeadline for Compliance with Nasdaq Listing Requirements
OneMedNet Corporation has until September 8, 2025, to regain compliance with Nasdaq listing requirements after receiving a notification from Nasdaq regarding deficiencies in its Market Value of Listed Securities (MVLS) and stockholders' equity. The company must achieve an MVLS of at least $35 million for ten consecutive business days within this compliance period to meet Nasdaq's standards. Failure to do so may result in a delisting notice, although the company can appeal any adverse decisions. Currently, the compliance issues do not affect the trading of OneMedNet's securities on Nasdaq.
Compliance Period DeadlineDeadline for Compliance with Nasdaq Listing Rule
Noodles & Company faces a deadline on June 23, 2025, to comply with Nasdaq's Minimum Bid Price Requirement after receiving a notification about non-compliance on December 24, 2024. The requirement stipulates a minimum closing bid price of $1.00 per share, which the company failed to maintain for 30 consecutive business days. During the 180-day compliance period, the company must ensure its stock price meets this requirement for at least ten consecutive days. Failure to comply may result in delisting, though the company is exploring options, including a potential reverse stock split, to regain compliance.
Deadline for complianceCompliance Deadline for Nasdaq Listing Requirements
Weyco Group, Inc. must demonstrate compliance with Nasdaq's independent director requirement by August 27, 2025, following a recent vacancy on the Board due to the resignation of a director. The company is currently seeking candidates to fill the Board vacancy, as it no longer meets the Nasdaq Listing Rule 5605(b)(1) which mandates that a majority of the Board consists of independent directors. There is a possibility that if compliance is not regained within the cure period, Weyco may face delisting, which could have substantial implications for its market standing and investor confidence.
Regulatory Compliance Deadline